右腋动脉置管用于静脉-动脉体外膜氧合的单中心回顾性研究
结果显示右腋动脉置管局部并发症率低,但30天和1年死亡率分别为36.2%和49.4%;因缺乏股-股置管对照组,无法得出腋动脉优于股动脉的结论。
要点
- 右腋动脉置管VA-ECMO局部并发症率低,出血4%、局部感染1.7%。
- 30天死亡率为36.2%,1年死亡率为49.4%。
- 因无股-股置管对照组,无法判定腋动脉置管是否优于股动脉。
核心结论
- 右腋动脉置管是安全可靠的VA-ECMO支持方法,局部并发症率低。
- 因缺乏股-股置管对照组,无法得出腋动脉置管优于股动脉置管的明确结论。
主要发现
- 适应证为任何原因的心源性休克78例(44.8%)或心脏术后综合征96例(55.2%)。
- 30天死亡率为36.2%(63例),1年死亡率为49.4%(86例);撤除VA-ECMO支持患者的1年生存率为72.7%(88例)。
- 腋动脉置管并发症:出血7例(4%)、局部感染3例(1.7%)、上肢缺血2例(1.1%)、臂丛神经损伤1例(0.6%);9例(5.2%)需要左心室卸载。
- VA-ECMO支持中位持续时间为7天(范围1-26天)。
临床怎么用
- 右腋动脉置管可作为非紧急VA-ECMO支持的安全选择,需关注局部出血、感染、上肢缺血和臂丛神经损伤等并发症。
局限性
- 为单中心回顾性研究,缺乏股-股置管对照组,无法比较腋动脉与股动脉置管的优劣。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Our goal was to assess the safety, outcomes and complication rate of axillary artery cannulation for venoarterial extracorporeal membrane oxygenation (VA-ECMO). METHODS: A retrospective analysis was conducted on data obtained from the review of medical charts of all consecutive patients undergoing VA-ECMO implantation between January 2013 and December 2017 at a teaching hospital. Only patients with right axillary VA-ECMO implantation in a non-emergency setting were included. Post-procedural outcomes and local and systemic complications were analysed. RESULTS: One hundred and seventy-four [131 male (75.3%), 43 female (24.7%); mean age 56.8 ± 15.1 years] patients underwent femoral-axillary VA-ECMO. Indications were cardiogenic shock from any cause (n = 78, 44.8%) or post-cardiotomy syndrome (n = 96, 55.2%). Fifty-three (30.5%) patients died while on VA-ECMO support. At the time of VA-ECMO ablation, 89 (51.1%) patients had recovered; 13 (7.5%) patients were bridged to a long-term mechanical support device and 19 (10.9%) patients underwent heart transplants. Thirty-day and 1-year mortality was 36.2% (n = 63) and 49.4% (n = 86), respectively. The 1-year survival rate of patients who were weaned from VA-ECMO support was 72.7% (n = 88). The complications of axillary cannulation were bleeding (n = 7, 4%), local infection (n = 3, 1.7%), upper limb ischaemia (n = 2, 1.1%) and brachial plexus injury (n = 1, 0.6%). Left ventricle unloading was required for 9 (5.2%) patients. The median duration of VA-ECMO support was 7 (range 1-26) days. CONCLUSIONS: Right axillary artery cannulation is a safe and reliable method for VA-ECMO support with a low rate of local complications. In the absence of a control group with femoro-femoral cannulation, no definitive conclusion about the superiority of axillary over femoral cannulation can be drawn.
引用
- Pisani A, Braham W, Brega C, et al. Right axillary artery cannulation for venoarterial extracorporeal membrane oxygenation: a retrospective single centre observational study. Eur J Cardiothorac Surg. 2021. PMID: 33313742. doi:10.1093/ejcts/ezaa397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。